Approximately one in five people who suffer from migraines also experience restless leg syndrome, which is approximately twice the prevalence observed in the general population. This increase in frequency is very noticeable among patients who endure chronic headaches and migraines with visual auras. A meta-analysis detailing these patterns was published in the Journal of Sleep Research.
Migraine is a neurological disorder characterized by repeated attacks of throbbing head pain, often accompanied by nausea and extreme sensitivity to light and sound. Restless legs syndrome is a sensorimotor condition defined by an overwhelming urge to move the lower extremities. Patients usually experience uncomfortable crawling and painful sensations, especially worse at night and at rest, with temporary relief only provided by physical movement.
Medical experts note that these two different symptoms often appear in the same patient. To better understand this overlap, Simona Raimo, a researcher at the University of Magna Graecia in Catanzaro, Italy, led a team to investigate the exact prevalence and clinical factors linking the two diseases. The researchers aimed to aggregate existing data to provide clear clinical guidance on how to manage patients facing both diseases simultaneously.
Single medical studies often have a limited number of participants, which can severely limit the statistical reliability of their conclusions. To overcome this hurdle, the researchers conducted a meta-analysis, a statistical method that pools data from multiple independent studies to reveal broader patterns. Raimo and her team ultimately isolated 30 previously published high-quality studies.
In total, the aggregated data included 20,781 adult participants diagnosed with migraine. Within this large sample, 3,343 people had a complete diagnosis of restless legs syndrome. Researchers combined available hospital data to calculate an overall pooled prevalence of 20 percent. For comparison, restless legs syndrome affects approximately 5 to 10 percent of the general population.
The researchers also looked at demographic characteristics to see if certain groups were at higher risk. Aging emerged as a consistent factor across reviewed studies. Older adults naturally experience gradual changes in dopamine production and iron metabolism, which may explain the higher rates of sleep disturbances in the elderly population. Although migraine is generally more prevalent in women, gender did not result in statistically significant differences in the co-occurrence of the two symptoms.
The specific type of migraine a patient experiences plays a large role in their overall risk profile. Migraine with aura involves sensory disturbances, such as seeing flashing lights or experiencing blind spots, before the actual head pain begins. Researchers found a strong association between restless leg syndrome and both chronic migraine and migraine with aura.
Conversely, no association was found for individuals experiencing episodic migraine without aura. Researchers suggest that as migraines become more frequent and progress to a chronic condition, physical signs of sleep disturbance may become more apparent. Disease chronicity processes can amplify shared neurophysiological pathways in the human nervous system.
This progression is consistent with a medical concept known as central sensitization. When the brain and spinal cord receive continuous pain signals over many years, the nervous system can become overreactive. Normal sensory input is suddenly processed as a painful or extremely unpleasant sensation. Researchers propose that chronic sensory input from frequent headaches and sensory dysregulation of restless legs amplify this heightened state of physiological alertness.
Beyond clinical diagnosis, behavioral symptoms greatly influence the co-occurrence of these symptoms. Patients dealing with both illnesses were much more likely to report severe depressive symptoms, overall pain intensity, and poor sleep quality compared to those with only migraines. Symptoms of anxiety did not reach a statistically significant association, suggesting that mental strain leans more toward depression than physical hyperarousal.
Sleep disorders play a particularly detrimental role in this dual cycle. Restless legs syndrome often involves involuntary muscle spasms that occur during actual sleep. These sudden movements cause small nervous system arousals known as microarousals, which prevent a person from reaching a deep restorative rest phase. It is well established that severe sleep deprivation can trigger severe migraines, creating a negative feedback loop where sleep deprivation creates physical pain, and physical pain prevents rest.
The precise biological mechanisms linking migraines and restless leg syndrome remain an active area of extensive scientific research. One leading theory involves the brain’s dopaminergic system. Dopamine is a chemical messenger that helps the nervous system regulate bodily movement, a person’s mood, and sensory processing.
In restless legs syndrome, abnormalities in certain dopamine pathways alter sensory processing in the spinal cord and cortex, causing nighttime tingling. There is new medical evidence that the brains of people with migraine become highly sensitive to dopamine. This heightened sensitivity can cause physical symptoms, such as frequent yawning, severe nausea, and gastrointestinal problems, just before a headache occurs.
Iron regulation provides another potential biological redundancy. Iron is a necessary molecular element for the human brain to properly synthesize dopamine. Patients with restless legs syndrome often exhibit iron deficiency in the central nervous system, and people who experience frequent migraines often exhibit abnormal iron accumulation in certain deep regions of the brain.
Recognizing this medical duplication has immediate implications for patient care, primarily because commonly prescribed medications can cause harmful physical interactions. Doctors often prescribe certain antidepressants and anti-nausea medications to help patients manage migraine symptoms. Some of these medications can inadvertently cause or worsen the unpleasant physical sensations associated with restless legs syndrome.
The opposite medical response is also true in many hospital settings. Dopamine agonists are a specific class of drugs that are commonly used to calm limb movements in patients with movement disorders. The same drug can cause severe headache attacks when given to people with a history of migraines. The researchers suggest that clinicians screen migraine patients for sleep disturbances before finalizing drug protocols.
If a patient suffers from both symptoms, doctors may need to switch to alternative medications, such as certain anticonvulsants, that can calm inflamed nerves at the same time without worsening either disease. The study authors also recommend non-pharmacological interventions such as strict sleep hygiene protocols, psychotherapy, and regular physical exercise. These lifestyle modifications can improve sleep efficiency and reduce symptoms of depression without the risk of dangerous drug interactions.
The researchers outlined several limitations in the available clinical data. Thirty studies utilized different diagnostic questionnaires to identify sleep disorders, introducing a high degree of statistical heterogeneity in the final results. Few previous studies have classified patients using the latest international criteria for headache disorders.
Future studies should incorporate modern imaging techniques to look at the brains of patients experiencing both conditions simultaneously. Tracking iron levels, dopamine receptor activity, and brain electrical excitability over time could pinpoint the biological origin of this overlap. By tracking these variables over several years, scientists hope to develop targeted therapies that completely calm the nervous system.
The study, “Migraine and restless legs syndrome: A meta-analysis,” was authored by Florindo d’Onofrio, Maria Cropano, Giada Panzino, Mariachiara Gaita, Giulio Cicarelli, Piero Barbanti, Gerardo Casucci, Simona Raimo, and Antonio Costanzo.
